![Levofloxacin Desethylene Diformyl Impurity ;Desethylene Diformyl Levofloxacin ; N,N’-Desethylene-N,N’-diformyl Levofloxacin ; (S)-9-Fluoro-10-[formyl[2-(formylmethylamino)ethyl]amino]-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | 151377-74-1](http://drjcrbio.com/wp-content/themes/shopperpress/thumbs/DRJC-LVFX-002.jpg)
Levofloxacin Desethylene Diformyl Impurity ;Desethylene Diformyl Levofloxacin ; N,N’-Desethylene-N,N’-diformyl Levofloxacin ; (S)-9-Fluoro-10-[formyl[2-(formylmethylamino)ethyl]amino]-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | 151377-74-1
Description
| Code: JCLEV-02 |
| CAS: 151377-74-1 |
| Chemical Formula: C18H18FN3O6 |
| Molecular Weight: 391.35 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Levofloxacin Desethylene Diformyl Impurity ;Desethylene Diformyl Levofloxacin ; N,N’-Desethylene-N,N’-diformyl Levofloxacin ; (S)-9-Fluoro-10-[formyl[2-(formylmethylamino)ethyl]amino]-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | 151377-74-1 is useful as reference Impurity standard. |
